[ASAP] Development and Validation of Novel Z-360-Based Macromolecules for the Active Targeting of CCK2-R

AI Summary

This article discusses the development and validation of novel macromolecules based on Z-360 for the active targeting of the CCK2-R. The research focuses on creating new compounds that can specifically target CCK2-R, a receptor associated with cancer. This novel approach could have significant implications for targeted drug delivery and cancer treatment.